Alaunos Therapeutics Inc Market Cap ($2.29 Million)
Market Cap & Net Worth: Alaunos Therapeutics Inc (TCRT)
Alaunos Therapeutics Inc market cap. Alaunos Therapeutics Inc (NASDAQ:TCRT) has a market capitalization of $2.29 Million ($2.29 Million) as of November 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29897 globally and #6106 in its home market, demonstrating a -35.86% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Alaunos Therapeutics Inc's stock price $1.95 by its total outstanding shares 2927135 (2.93 Million). Also see TCRT cash flow metrics for how efficiently the company converts equity into cash flow.
Alaunos Therapeutics Inc Market Cap History (2015–2026)
Alaunos Therapeutics Inc market cap history from 2015 to 2026. Data shows change from $3.65 Billion to $5.71 Million (-45.64% CAGR). Check TCRT stock price and chart for real-time trading data and today's change.
Index Memberships
Alaunos Therapeutics Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.62 Trillion | 0.00% | #864 of 976 |
|
NASDAQ Composite
IXIC
|
$40.09 Trillion | 0.00% | #2765 of 3165 |
Weight: Alaunos Therapeutics Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Alaunos Therapeutics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Alaunos Therapeutics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Alaunos Therapeutics Inc to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1890.93x
Alaunos Therapeutics Inc's market cap is 1890.93 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.35 Billion | $6.86 Million | -$165.30 Million | 342.37x | N/A |
| 2017 | $1.82 Billion | $6.39 Million | -$54.32 Million | 284.51x | N/A |
| 2018 | $821.06 Million | $146.00K | -$53.12 Million | 5623.71x | N/A |
| 2021 | $478.59 Million | $398.00K | -$78.75 Million | 1202.48x | N/A |
| 2022 | $285.40 Million | $2.92 Million | -$37.73 Million | 97.67x | N/A |
| 2023 | $30.73 Million | $5.00K | -$35.14 Million | 6146.98x | N/A |
| 2024 | $5.58 Million | $10.00K | -$4.68 Million | 557.62x | N/A |
| 2025 | $9.45 Million | $5.00K | -$4.18 Million | 1890.93x | N/A |
Competitor Companies of TCRT by Market Capitalization
Companies near Alaunos Therapeutics Inc in the global market cap rankings as of November 3, 2026. Also see TCRT total asset value for a full breakdown of the balance sheet.
Key companies related to Alaunos Therapeutics Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #182 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $558.88 |
| #371 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $927.89 |
| #412 | CSL Ltd | AU:CSL | $68.91 Billion | AU$200.73 |
| #495 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $221.72 |
Market Capitalization of Alaunos Therapeutics Inc (2015–2026)
Market capitalization of Alaunos Therapeutics Inc from 2015 to today. Between 2015 and today, Alaunos Therapeutics Inc's market cap moved from $3.65 Billion to $ 5.71 Million, with a yearly change of -45.64%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $5.71 Million | -39.63% |
| 2025 | $9.45 Million | +69.55% |
| 2024 | $5.58 Million | -81.86% |
| 2023 | $30.73 Million | -89.23% |
| 2022 | $285.40 Million | -40.37% |
| 2021 | $478.59 Million | -56.75% |
| 2020 | $1.11 Billion | -46.61% |
| 2019 | $2.07 Billion | +152.41% |
| 2018 | $821.06 Million | -54.83% |
| 2017 | $1.82 Billion | -22.62% |
| 2016 | $2.35 Billion | -35.62% |
| 2015 | $3.65 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 2nd, 2026 the market cap of Alaunos Therapeutics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.29 Million USD |
| MoneyControl | $2.29 Million USD |
| MarketWatch | $2.29 Million USD |
| marketcap.company | $2.29 Million USD |
| Reuters | $2.29 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Alaunos Therapeutics Inc
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Th… Read more